Ipca Laboratories (NSE:IPCALAB) 3-Year EBITDA Growth Rate

: 2.80% (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

Ipca Laboratories's EBITDA per Share for the three months ended in Dec. 2023 was ₹16.63.

During the past 12 months, Ipca Laboratories's average EBITDA Per Share Growth Rate was 26.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 2.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 19.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ipca Laboratories was 48.20% per year. The lowest was -18.80% per year. And the median was 20.00% per year.

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ipca Laboratories 3-Year EBITDA Growth Rate Distribution

For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Ipca Laboratories's 3-Year EBITDA Growth Rate falls into.

Ipca Laboratories 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Ipca Laboratories (NSE:IPCALAB) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Ipca Laboratories 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipca Laboratories (NSE:IPCALAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (NSE:IPCALAB) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

524494:India

Address

125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067

Website

https://www.ipca.com

Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (NSE:IPCALAB) Headlines

No Headlines